2018
Human Borrelia miyamotoi infection in California: Serodiagnosis is complicated by multiple endemic Borrelia species
Krause PJ, Carroll M, Fedorova N, Brancato J, Dumouchel C, Akosa F, Narasimhan S, Fikrig E, Lane RS. Human Borrelia miyamotoi infection in California: Serodiagnosis is complicated by multiple endemic Borrelia species. PLOS ONE 2018, 13: e0191725. PMID: 29420552, PMCID: PMC5805228, DOI: 10.1371/journal.pone.0191725.Peer-Reviewed Original ResearchConceptsBorrelia miyamotoi infectionMiyamotoi infectionB. miyamotoiB. miyamotoi diseaseB. miyamotoi infectionB. burgdorferi infectionHealth care professionalsWhole cell lysatesSeropositive subjectsSufficient serumClinical dataBurgdorferi infectionAntibody assaysSeropositive samplesCare professionalsBorrelia antigensInfectionSerumAntibodiesBorrelia burgdorferiAntigenI. pacificus ticksMiyamotoiTick infectionFever spirochetes
2010
Lyme borreliosis vaccination: the facts, the challenge, the future
Schuijt TJ, Hovius JW, van der Poll T, van Dam AP, Fikrig E. Lyme borreliosis vaccination: the facts, the challenge, the future. Trends In Parasitology 2010, 27: 40-47. PMID: 20594913, DOI: 10.1016/j.pt.2010.06.006.Peer-Reviewed Original ResearchConceptsBorrelia burgdorferi sensu lato groupPrevalent arthropod-borne diseaseAnti-tick vaccinesLyme borreliosisArthropod-borne diseaseSensu lato groupTick proteinsTick vectorIxodes ticksNovel vaccination strategiesTicksMammalian hostsVaccination strategiesLyme diseaseVaccine candidatesBorreliosisBorrelia antigensVaccineAntigenDiseaseBorreliaOuter membrane proteinsWestern worldFuture candidatesSpirochetes